Home
>
US Stocks
>
Regenxbio Inc
Regenxbio Inc
RGNX

Regenxbio Inc (RGNX)

$35.253.56%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$35.97
Today Low/High$35.15 / $36.41
52 Week Low/High$27.02 / $50.26
P/E ratio-9.86
Market Cap$1.56B

Company Details

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. REGENXBIO's NAV Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO and its third-party NAV Technology Platform Licensees are applying the NAV Technology Platform in the development of a broad pipeline of candidates in multiple therapeutic areas.
OrganisationRegenxbio Inc
HeadquatersRockville, Maryland, US
Employees306
IndustryHealth Technology
CEOKenneth Mills

Discover more

Frequently Asked Questions

What is Regenxbio Inc (RGNX) share price today?

Can Indians buy Regenxbio Inc (RGNX) shares?

How can I buy Regenxbio Inc (RGNX) shares from India?

Can Fractional shares of Regenxbio Inc (RGNX) be purchased?

What are the documents required to start investing in Regenxbio Inc (RGNX) stocks?

We are a SEBI registered investement advisor